Geneva Hospital Hits Pause Button on Ebola Vaccine Trial

Drug Industry Daily
A A
Investigators have temporarily halted a trial of NewLink Genetics’ experimental Ebola vaccine after several patients reported unexpected side effects.

To View This Article:

Login

Subscribe To Drug Industry Daily